CEL-SCI Corporation
General ticker "CVM" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $44.9M (TTM average)
CEL-SCI Corporation does not follow the US Stock Market performance with the rate: -29.4%.
Estimated limits based on current volatility of 3.2%: low 1.58$, high 1.69$
Factors to consider:
- Total employees count: 17381 as of 1995
- Top business risk factors: Net losses continue, Capital shortage, Regulatory and compliance, Clinical trial delays, Product liability
- Current price 62.2% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-09-30 to 2027-09-30
- 2025-09-30 to 2026-09-30 estimated range: [4.36$, 15.64$]
- 2026-09-30 to 2027-09-30 estimated range: [3.05$, 11.44$]
Financial Metrics affecting the CVM estimates:
- Negative: with PPE of -1.1 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -47.73 <= 0.28
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
- Negative: -0.75 < Inventory ratio change, % of 0
- Positive: 42.26 < Shareholder equity ratio, % of 56.67 <= 63.63
- Negative: 0.75 < Interest expense per share per price, % of 1.81
- Negative: -0.14 < Industry inventory ratio change (median), % of 0
Short-term CVM quotes
Long-term CVM plot with estimates
Financial data
| YTD | 2023-09-30 | 2024-09-30 | 2025-09-30 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $31.48MM | $26.35MM | $24.81MM |
| Operating Income | $-31.48MM | $-26.35MM | $-24.81MM |
| Non-Operating Income | $-0.50MM | $0.09MM | $-0.60MM |
| Interest Expense | $0.68MM | $0.75MM | $0.65MM |
| R&D Expense | $22.47MM | $18.16MM | $15.89MM |
| Income(Loss) | $-31.98MM | $-26.26MM | $-25.41MM |
| Net Income(Loss)* | $-31.98MM | $-26.92MM | $-25.41MM |
| Stockholders Equity | $13.21MM | $12.87MM | $15.96MM |
| Inventory | $2.25MM | $1.02MM | $0.30MM |
| Assets | $30.53MM | $26.99MM | $28.16MM |
| Operating Cash Flow | $-22.85MM | $-18.81MM | $-17.12MM |
| Capital expenditure | $0.37MM | $0.09MM | $38.11MM |
| Investing Cash Flow | $-0.37MM | $-0.11MM | $-0.04MM |
| Financing Cash Flow | $4.69MM | $19.51MM | $23.37MM |
| Earnings Per Share** | $-21.58 | $-13.54 | $-6.27 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.